BCL2 and acute myeloid leukemia: MYB functions as a central transcriptional coordinator in AML pathogenesis, governing leukemogenesis initiation and disease persistence by enhancing LICs’ self-renewal capacity and viability through stimulation of downstream tumorigenic pathways involving MYC, CDK6, BCL2, and MCL1 [30].